Home / Blood Glucose Control (page 16)

Blood Glucose Control

Making Telemedicine Work for Diabetes Care: Structuring Virtual Visits for Better Outcomes

Doctor conducting a telemedicine consultation with a diabetes patient using glucose monitoring tools on her desk

Telemedicine for diabetes management has transformed the landscape of chronic care. As healthcare systems integrate digital solutions beyond the pandemic, one thing is clear: virtual visits are here to stay. But making telehealth work for diabetes requires more than video calls—it demands structure, thoughtful planning, and patient-centered design. This article …

Read More »

DSMES 2.0: What the New ADA Standards Mean for Referral, Delivery, and Follow‑Up

A diabetes educator demonstrating a glucose meter during a DSMES session with diverse patients and digital health tools.

The future of diabetes care hinges on personalized support—and that includes updates to how we educate and empower patients. With the American Diabetes Association’s (ADA) 2025 Standards of Care redefining the framework, education for self-managing diabetes in 2026 is no longer a one-time intervention but a lifelong journey. Clinicians, educators, …

Read More »

From Screening to Referral: Integrating Food Insecurity and Housing Instability into Diabetes Visits

Doctor discussing social needs with diabetes patient, showing screening form, food bank, eviction notice, and public transportation to illustrate social determinants of health diabetes.

Social determinants of health in diabetes, like food insecurity and housing instability, are often the invisible drivers behind high A1C levels and missed appointments. Yet these critical factors are rarely addressed during routine visits. What if a few simple questions could lead to better glycemic control and fewer complications? This …

Read More »

When Less Is More: How to Safely De‑Intensify Diabetes Therapy

A female doctor shows a glucose meter to an elderly female patient during a diabetes consultation in a warm, home-like medical setting.

As more patients with diabetes achieve and maintain glycemic targets, the conversation is shifting from “how can we intensify therapy?” to “when is it safe and appropriate to de‑intensify diabetes therapy?” De‑intensify diabetes therapy is becoming a high‑value clinical goal for many clinicians caring for adults with type 2 diabetes, …

Read More »

Moving Past Low Sugar: How to Recommend Evidence‑Based Eating Patterns

A colorful display of healthy foods including salmon, vegetables, grains, and nuts with a chalkboard reading "Evidence-Based Eating"

Clinicians often hear patients ask, “What should I eat?” Yet, the focus on low sugar alone can leave both patients and providers frustrated. The term “low sugar” lacks nuance, and without context, it doesn’t translate into an actionable plan for people living with diabetes. What clinicians really need are clear, …

Read More »

Why Screening for Sleep Apnea Should Be Standard in Diabetes Care

A CPAP nasal mask and tubing placed beside diabetes and sleep apnea screening questionnaires, including the STOP-Bang tool.

In clinical practice, the link between sleep apnea diabetes screening and improved patient outcomes is becoming increasingly clear. Obstructive sleep apnea (OSA) is both a contributor to and a consequence of poor glycemic control, yet it remains under‑recognized in diabetes management. If clinicians fail to screen for sleep apnea in …

Read More »

Prescribing Exercise in Type 2 Diabetes: What the Evidence Says About Type, Dose, and Impact

A glucose meter, exercise prescription form, athletic shoes, and dumbbell illustrating the integration of fitness into type 2 diabetes care.

Exercise is a cornerstone of type 2 diabetes care, yet clinicians often struggle with translating broad guidelines into practical, individualized “exercise prescriptions.” The focus keyword in this article, exercise prescription for type 2 diabetes, reflects a high‑intent search term that clinicians, diabetes educators, and patients frequently use when seeking actionable …

Read More »

From A1C to TIR – Rethinking Glycemic Targets for Better Long‑Term Outcomes

A glucose meter reading 117 mg/dL placed over lab results showing Hemoglobin A1c and a Time in Range (TIR) chart with green, yellow, and red bars.

For decades, clinicians have relied on A1C as the primary benchmark for diabetes control. Yet many patients and providers now wonder: does a single quarterly number truly reflect daily glucose fluctuations and risks? As continuous glucose monitoring (CGM) becomes more accessible, the metric known as Time in Range (TIR) has …

Read More »

CGM in Primary Care: Bridging the Endocrinology Gap

A smartphone displaying CGM glucose data surrounded by diabetes monitoring tools including a stethoscope, insulin pen, syringe, and CGM sensor on a clinic desk.

Could continuous glucose monitoring (CGM) soon become the norm in primary care? Once considered a specialty tool reserved for endocrinologists, CGM is now recommended far earlier in diabetes treatment — even for patients with type 2 diabetes on basal insulin alone. Despite these guideline shifts, primary care adoption has lagged. …

Read More »

Reimagining Remission: Can Short‑Term Intensive Therapy Reset Type 2 Diabetes?

A diabetes management setup featuring a glucose meter, vegetables, apple, insulin pen, and a notepad labeled "Intensive Therapy"

Could the conventional “lifelong treatment” model for type 2 diabetes be rethought? Recent trials suggest that short‑term intensive therapy may offer more than transient glycemic control—it might trigger lasting remission in newly diagnosed patients. Such interventions, combining aggressive pharmacologic therapy or insulin with lifestyle change, show potential to preserve β‑cell …

Read More »